In many cancers, including pancreatic cancer, cells of the tumour microenvironment affect progression of cancer pathology and scRNA-seq identified ATF3 in subsets of fibroblasts and immune cells for both murine and human models of PDAC [33]. This evidence concerns the gene ATF3 and pancreatic neoplasm.